# GLP-1s and mood · PepVault guides

Source: https://pepvault.app/guides/glp-1s-and-mood

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# GLP-1s and mood: depression, anxiety and what the FDA review found

Reviewed November 2026 18 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Do Ozempic, Wegovy, Mounjaro or Zepbound cause depression? The FDA's 2026 review, the labels' warning removed, the trial rates against placebo, and what helps.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 18
- **Questions:** 6
- **Compounds:** 3

## The short answer

The FDA found no increased risk of depression, anxiety or suicidal thoughts on GLP-1 medicines. Its January 2026 review pooled 91 placebo-controlled trials with 107,910 people, and Wegovy, Zepbound and Saxenda dropped their suicidal-thoughts warning in February 2026. In the weight trials, depression and anxiety ran slightly lower on the drug than on placebo. New or worsening low mood is still worth a call to your prescriber.

Every number checked at its primary source · Nov 20, 2026 · [18 sources](https://pepvault.app/guides/glp-1s-and-mood#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Strong for reassurance: an FDA meta-analysis of 91 placebo-controlled trials, two maker-funded pooled trial analyses that measured mood at every visit, and large observational studies. The trials mostly excluded people with serious psychiatric illness.

## Do GLP-1s cause depression or suicidal thoughts?

The FDA's answer, after the largest review yet, is no. GLP-1 medicines copy a gut hormone, GLP-1, that lowers blood sugar after a meal and acts in the parts of the brain that control appetite. In July 2023, after reports of suicidal thoughts in people taking them, the agency opened an investigation. Its first look, published in January 2024, found no evidence that these medicines cause suicidal thoughts or actions, but it could not rule out a small risk because the trials held so few events[2](https://pepvault.app/guides/glp-1s-and-mood#source-2).

So the FDA ran a bigger test. It pooled **91 placebo-controlled trials with 107,910 people** (60,338 on a GLP-1 medicine, 47,572 on a placebo, a dummy treatment) and found no increased risk of suicidal thoughts or behaviour, and none for anxiety, depression, irritability or psychosis either. It also compared 2,243,138 people with type 2 diabetes in its Sentinel insurance-claims network who started a GLP-1 medicine or an SGLT2 inhibitor, another diabetes drug, and found no increase in self-harm on the GLP-1 side. On January 13, 2026 it asked the makers of Saxenda, Wegovy and Zepbound to remove the warning[1](https://pepvault.app/guides/glp-1s-and-mood#source-1).

Europe reached the same place earlier. In April 2024 the safety committee of the European Medicines Agency (PRAC), which had started with semaglutide and liraglutide and widened its review to the class, concluded that the evidence does not support a causal link with suicidal or self-injurious thoughts and actions, so no change to the product information was needed[3](https://pepvault.app/guides/glp-1s-and-mood#source-3).

<!--promo-->

If your mood feels different after starting or stepping up a dose, PepVault's daily check-in rates your mood beside energy and sleep, and the side-effect log keeps the symptom, its strength on a 1 to 5 scale, the date and a note. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-mood-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

If your mood feels different after starting or stepping up a dose, PepVault's daily check-in rates your mood beside energy and sleep, and the side-effect log keeps the symptom, its strength on a 1 to 5 scale, the date and a note.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What do the Ozempic, Wegovy, Mounjaro and Zepbound labels say now?

The weight-loss labels carried a warning; the diabetes labels never did. The warning was not built on GLP-1 data: until its February 2026 revision, Wegovy's label read "Suicidal behavior and ideation have been reported in clinical trials with other weight management products" and asked prescribers to watch for depression[18](https://pepvault.app/guides/glp-1s-and-mood#source-18). The FDA traces it to reports with a variety of older weight-loss medicines[1](https://pepvault.app/guides/glp-1s-and-mood#source-1). The current US labels, read on DailyMed in November 2026:

| Label (medicine) | Mood warning today | Mood or sleep effects in its trial tables, drug against placebo |
| --- | --- | --- |
| Ozempic (semaglutide, diabetes) | Never had one | None listed |
| Mounjaro (tirzepatide, diabetes) | Never had one | None listed |
| Wegovy (semaglutide, weight) | Removed February 2026 | Adults: none listed. Teens (12 and older): anxiety 4% against 2% |
| Zepbound (tirzepatide, weight) | Removed February 2026 | None listed |
| Saxenda (liraglutide, weight) | Removed February 2026 | Adults: anxiety 2.0% against 1.6%, insomnia 2.4% against 1.7%. Teens: depression 4% against 2.4% |

The tables list only effects reported more often on the drug than on placebo, at the labels' cut-off of 2% or more in adults and 3% or more in teens; the teen rows come from single trials of 201 teens (Wegovy) and 251 teens (Saxenda), where one or two people move a percentage[4](https://pepvault.app/guides/glp-1s-and-mood#source-4) [6](https://pepvault.app/guides/glp-1s-and-mood#source-6). Ozempic and Mounjaro list no mood effect at all[7](https://pepvault.app/guides/glp-1s-and-mood#source-7) [8](https://pepvault.app/guides/glp-1s-and-mood#source-8).

One mood line stays in all five labels, and it matters: the patient leaflets list **anxiety, irritability or mood changes as signs of low blood sugar**, a risk the labels say is higher when a GLP-1 is taken with insulin or a sulfonylurea[4](https://pepvault.app/guides/glp-1s-and-mood#source-4) [5](https://pepvault.app/guides/glp-1s-and-mood#source-5) [6](https://pepvault.app/guides/glp-1s-and-mood#source-6) [7](https://pepvault.app/guides/glp-1s-and-mood#source-7) [8](https://pepvault.app/guides/glp-1s-and-mood#source-8). With those medicines, a sudden shaky, irritable spell is worth a glucose check before anything else.

## How often did depression and anxiety show up in the trials?

Less often on the drug than on placebo. The makers' weight trials measured mood at every visit with two standard questionnaires: the PHQ-9, nine questions scored 0 to 27, where 0 to 4 means no or minimal depression, and the Columbia scale for suicidal thoughts. Pooled analyses of the semaglutide trials (STEP 1, 2 and 3) and the tirzepatide trials (SURMOUNT 1, 2 and 3) give these rates[9](https://pepvault.app/guides/glp-1s-and-mood#source-9) [10](https://pepvault.app/guides/glp-1s-and-mood#source-10):

| Measure | Semaglutide 2.4 mg (Wegovy) | Placebo | Tirzepatide (Zepbound) | Placebo |
| --- | --- | --- | --- | --- |
| People in the pool | 2,116 | 1,261 | 2,806 | 1,250 |
| Any psychiatric side effect | 9.8% | 10.5% | 6.8% | 8.2% |
| Anxiety | 3.3% | 4.2% | 1.5% | 3.5% |
| Depression or depressed mood | 2.8% | 3.2% | 1.5% | 2.1% |
| Trouble sleeping | 3.4% | 3.6% | 2.9% | 2.3% |
| Suicidal thoughts on the Columbia scale | 1% or fewer | 1% or fewer | 0.6% | 0.6% |
| PHQ-9 score at the end (68 or 72 weeks) | 2.0 | 2.4 | 1.9 | 2.4 |

Across the semaglutide trials, 2.8% of people on the drug and 4.1% on placebo had a PHQ-9 score of 15 or more at some point after the start, the level that calls for a mental-health assessment[9](https://pepvault.app/guides/glp-1s-and-mood#source-9). On tirzepatide, 18.2% moved to a worse PHQ-9 band against 24.3% on placebo, and 52.4% moved to a better one against 41.8%[10](https://pepvault.app/guides/glp-1s-and-mood#source-10). The semaglutide analysis calls its drop in scores small and not clinically meaningful[9](https://pepvault.app/guides/glp-1s-and-mood#source-9): on both drugs, mood mostly held steady.

Who these numbers cover: the trials left out people with major depression in the past two years, a past suicide attempt, or severe illness such as schizophrenia or bipolar disorder, and both analyses were funded and co-written by the makers[9](https://pepvault.app/guides/glp-1s-and-mood#source-9) [10](https://pepvault.app/guides/glp-1s-and-mood#source-10). About one in five people in the tirzepatide pool had a past psychiatric diagnosis, and 7 to 9% took an antidepressant or a similar medicine[10](https://pepvault.app/guides/glp-1s-and-mood#source-10).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Titration](https://pepvault.app/glossary/titration)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)

## When do mood changes start on a GLP-1?

The trials found no stretch of weeks where mood turned bad on the drug. The STEP trials checked mood at weeks 12, 20, 36, 52 and 68, the SURMOUNT trials at weeks 12, 24, 36, 48, 60 and 72 plus four weeks after the last dose[9](https://pepvault.app/guides/glp-1s-and-mood#source-9) [10](https://pepvault.app/guides/glp-1s-and-mood#source-10). In the STEP trials, average scores rose a fraction in both groups through week 52 and stayed in the no-or-minimal range; by the end they sat lower on semaglutide[9](https://pepvault.app/guides/glp-1s-and-mood#source-9). In the SURMOUNT trials, scores fell more on tirzepatide than on placebo at every visit[10](https://pepvault.app/guides/glp-1s-and-mood#source-10).

What does change during the dose climb, called titration, is the body. Tiredness ran 11% on Wegovy against 5% on placebo, and 5 to 7% on Zepbound against 3%, and nausea is the most common effect of all, which Zepbound's label says comes mostly during the dose climb and eases over time[4](https://pepvault.app/guides/glp-1s-and-mood#source-4) [5](https://pepvault.app/guides/glp-1s-and-mood#source-5). A run of tired, queasy days can weigh on how a week feels, which is a reason to look at food, fluids and sleep before reading it as depression.

Stopping may be a different moment. A 2026 cohort study of people with type 2 diabetes in Shanghai hospital records found the risk of depression and anxiety disorders neutral or lower while they took a GLP-1, but higher after they stopped it than after stopping other diabetes drugs, and its authors single out anxiety; it is observational, so it shows a link rather than a cause[17](https://pepvault.app/guides/glp-1s-and-mood#source-17).

**Commonly reported:** quieter food thoughts and less guilt around eating, which many users describe as a lift in mood; and, for some, a flat, low-energy day or two after a dose step, which users tend to tie to eating much less.

## What did the big real-world studies find?

Independent researchers found the same or lower risk: one pooled 27 placebo-controlled trials, and four observational studies followed real patients' records rather than assigning a drug, comparing people who started a GLP-1 with people on another treatment for the same condition. A hazard ratio below 1 means fewer events on the GLP-1 side:

| Study | Who | What it found |
| --- | --- | --- |
| Ebrahimi 2025, 27 placebo-controlled trials | 59,396 adults with diabetes or obesity | Suicide-related events 0.047 against 0.042 per 100 person-years; no difference (rate ratio 0.76)[11](https://pepvault.app/guides/glp-1s-and-mood#source-11) |
| Ueda 2024, Sweden and Denmark registers | 124,517 GLP-1 starters against 174,036 SGLT2 starters, mostly type 2 diabetes | Suicide death 0.23 against 0.18 per 1,000 person-years (not significant); self-harm or suicide hazard ratio 0.83; new depression or anxiety 1.01[12](https://pepvault.app/guides/glp-1s-and-mood#source-12) |
| Wang 2024, US health records | 240,618 people with overweight or obesity | New suicidal thoughts on semaglutide against other weight-loss drugs: hazard ratio 0.27[13](https://pepvault.app/guides/glp-1s-and-mood#source-13) |
| Yu 2025, US health records | 16,321 matched pairs with overweight or obesity | Suicidal thoughts or attempts on tirzepatide against other weight-loss drugs: 17 against 33 people, hazard ratio 0.52[14](https://pepvault.app/guides/glp-1s-and-mood#source-14) |
| Liu 2026, US health records | 9,222 matched pairs of teens with obesity | Suicide-related events on semaglutide, liraglutide or tirzepatide against lifestyle care: hazard ratio 0.74; no difference for depression, and none against metformin[15](https://pepvault.app/guides/glp-1s-and-mood#source-15) |

One study pointed the other way. A 2024 analysis of the World Health Organization's database of suspected side effects found 45% higher odds of suicidal thoughts being reported with semaglutide than with all other drugs (a reporting odds ratio of 1.45)[16](https://pepvault.app/guides/glp-1s-and-mood#source-16). That kind of study counts reports sent in, not people at risk, so news coverage and who gets prescribed a drug move it; its own authors called for urgent clarification, and the FDA's later trial pool and Sentinel study are the larger tests of the question[1](https://pepvault.app/guides/glp-1s-and-mood#source-1). The FDA's verdict on the published studies as a whole: they do not support a causal link[1](https://pepvault.app/guides/glp-1s-and-mood#source-1).

## What helps if your mood dips on a GLP-1?

1. Write it down the day it happens: what you feel, how strong, and how many days since your last dose or dose step.
2. If you also take insulin or a sulfonylurea and feel shaky, sweaty or suddenly irritable, check your blood sugar first: the labels list mood changes as a sign of low blood sugar[4](https://pepvault.app/guides/glp-1s-and-mood#source-4) [7](https://pepvault.app/guides/glp-1s-and-mood#source-7).
3. Look at the basics of the week: how much you ate, protein, fluids and sleep. A large drop in food can feel like a drop in mood.
4. Tell your prescriber about new or worsening low mood, anxiety or any unusual change in mood or behaviour; the FDA asks patients to do exactly that[1](https://pepvault.app/guides/glp-1s-and-mood#source-1).
5. The FDA's advice to patients is to keep taking the medicine as prescribed and to discuss any concern with their prescriber[1](https://pepvault.app/guides/glp-1s-and-mood#source-1), and not to stop on their own[2](https://pepvault.app/guides/glp-1s-and-mood#source-2). Whether to change the dose, pause or switch is your prescriber's decision.
6. If you have depression or another mental-health condition already, tell your prescriber before you start, since the trials mostly left those patients out[9](https://pepvault.app/guides/glp-1s-and-mood#source-9) [10](https://pepvault.app/guides/glp-1s-and-mood#source-10).

<!--promo-->

PepVault's doctor's report shows your weekly mood trend from the check-in and lists each side effect you logged on the protocol, with its date and strength, so your prescriber sees the pattern in one place instead of from memory. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-mood-inline&mt=8)

<!--/promo-->

**When to get help** Thoughts of harming yourself are a reason to get help now, whatever the cause: in the US call or text 988, the Suicide and Crisis Lifeline, or your local emergency number elsewhere[1](https://pepvault.app/guides/glp-1s-and-mood#source-1).

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. US Food and Drug Administration. FDA requests removal of suicidal behavior and ideation warning from glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. Drug Safety Communication, January 13, 2026. [fda.gov](https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp)
2. US Food and Drug Administration. Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity. Drug Safety Communication, January 11, 2024. [fda.gov](https://www.fda.gov/drugs/drug-safety-communications/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type)
3. European Medicines Agency. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC), 8-11 April 2024. [ema.europa.eu](https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-april-2024)
4. Wegovy (semaglutide) injection and tablets, US prescribing information. Novo Nordisk. DailyMed, version 19, June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
5. Zepbound (tirzepatide) injection, US prescribing information. Eli Lilly. DailyMed, version 40, September 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
6. Saxenda (liraglutide) injection, US prescribing information. Novo Nordisk. DailyMed, version 22, June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
7. Ozempic (semaglutide) injection, US prescribing information. Novo Nordisk. DailyMed, version 20, June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
8. Mounjaro (tirzepatide) injection, US prescribing information. Eli Lilly. DailyMed, version 40, September 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
9. Wadden TA et al. Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials. JAMA Intern Med. 2024. [PubMed 39226070](https://pubmed.ncbi.nlm.nih.gov/39226070/)
10. Wadden TA et al. Psychiatric safety of tirzepatide in people with obesity and no known major psychopathology: a post hoc analysis of SURMOUNT. Obesity (Silver Spring). 2026. [PubMed 41537305](https://pubmed.ncbi.nlm.nih.gov/41537305/)
11. Ebrahimi P et al. Suicide and self-harm events with GLP-1 receptor agonists in adults with diabetes or obesity: a systematic review and meta-analysis. JAMA Psychiatry. 2025. [PubMed 40105856](https://pubmed.ncbi.nlm.nih.gov/40105856/)
12. Ueda P et al. GLP-1 receptor agonist use and risk of suicide death. JAMA Intern Med. 2024. [PubMed 39226030](https://pubmed.ncbi.nlm.nih.gov/39226030/)
13. Wang W et al. Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nat Med. 2024. [PubMed 38182782](https://pubmed.ncbi.nlm.nih.gov/38182782/)
14. Yu WS et al. Association of tirzepatide and the risk of suicide in a real-world cohort. Front Psychiatry. 2025. [PubMed 41334076](https://pubmed.ncbi.nlm.nih.gov/41334076/)
15. Liu TH et al. Psychiatric safety of GLP-1 and dual GIP/GLP-1 receptor agonists in adolescents with obesity. Diabetes Obes Metab. 2026. [PubMed 42736027](https://pubmed.ncbi.nlm.nih.gov/42736027/)
16. Schoretsanitis G et al. Disproportionality analysis from World Health Organization data on semaglutide, liraglutide, and suicidality. JAMA Netw Open. 2024. [PubMed 39163046](https://pubmed.ncbi.nlm.nih.gov/39163046/)
17. Zhang T et al. Association of GLP-1RA discontinuation and risk of depressive and anxiety disorders in people with type 2 diabetes: a cohort study. Nat Metab. 2026. [PubMed 42426287](https://pubmed.ncbi.nlm.nih.gov/42426287/)
18. Wegovy (semaglutide) injection and tablets, US prescribing information, section 5.10 (before its removal). Novo Nordisk. DailyMed archive, version 14, revised December 2025, published January 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=937258)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)

Ozempic, Wegovy and NAION: what the labels say as of November 2026, every large study with its absolute risk, the trial data, and what tirzepatide shows.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)

## Related guides

- Guide · GLP-1s

  ### [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)

  Ozempic and Wegovy side effects from the labels' trials, drug against placebo: nausea and the rest, when they start, how many days they last, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)

  Mounjaro and Zepbound side effects at 5, 10 and 15 mg against placebo, from the labels' trial tables: when they show up, how many stopped, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide
- Guide · GLP-1s

  ### [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)

  Food noise on a GLP-1: what the term means, how it is measured, what semaglutide and tirzepatide trials and users report, and what is known after stopping.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Titration](https://pepvault.app/glossary/titration)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
